• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药引起的肝脏疾病。发病率及预防

Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.

作者信息

Manoukian A V, Carson J L

机构信息

Division of Gastroenterology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, USA.

出版信息

Drug Saf. 1996 Jul;15(1):64-71. doi: 10.2165/00002018-199615010-00005.

DOI:10.2165/00002018-199615010-00005
PMID:8862964
Abstract

The nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently used medications worldwide for the treatment of a variety of common chronic and acute inflammatory conditions. The association between NSAIDs and liver disease is poorly documented, the exceptions being sulindac and, to a lesser degree, diclofenac. The incidence of liver disease is very low and is relatively unimportant compared with the risk of peptic ulcer disease and gastrointestinal bleeding. Reports of hepatic injury range from insignificant and transient liver enzyme elevation to severe and fulminant hepatitis.

摘要

非甾体抗炎药(NSAIDs)是全球范围内治疗各种常见慢性和急性炎症性疾病最常用的药物。NSAIDs与肝脏疾病之间的关联记录较少,舒林酸是个例外,双氯芬酸在较小程度上也是如此。肝脏疾病的发病率非常低,与消化性溃疡疾病和胃肠道出血的风险相比相对不那么重要。肝损伤的报告范围从无明显症状的短暂肝酶升高到严重的暴发性肝炎。

相似文献

1
Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.非甾体抗炎药引起的肝脏疾病。发病率及预防
Drug Saf. 1996 Jul;15(1):64-71. doi: 10.2165/00002018-199615010-00005.
2
Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.法国和西班牙非甾体抗炎药相关肝损伤:来自国家自发报告系统的分析
Fundam Clin Pharmacol. 2006 Aug;20(4):391-5. doi: 10.1111/j.1472-8206.2006.00416.x.
3
[Drug-induced lesion of the liver].[药物性肝损伤]
Voen Med Zh. 1987 Jun(6):60-1.
4
Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.65岁以下患者使用非甾体抗炎药相关的消化性溃疡和胃肠道出血。一项大型健康维护组织队列研究。
Arch Intern Med. 1995 Jul 10;155(13):1371-7.
5
Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
Arthritis Rheum. 1997 Feb;40(2):201-8. doi: 10.1002/art.1780400204.
6
[Hepatitis due to nonsteroidal anti-inflammatory agents].[非甾体抗炎药所致肝炎]
Ann Gastroenterol Hepatol (Paris). 1987 Dec;23(7):367-74.
7
Low-dose diclofenac, naproxen, and ibuprofen cohort study.低剂量双氯芬酸、萘普生和布洛芬队列研究。
Pharmacotherapy. 1999 Jul;19(7):854-9. doi: 10.1592/phco.19.10.854.31550.
8
Hepatotoxicity of non-narcotic analgesics.非麻醉性镇痛药的肝毒性
Am J Med. 1998 Jul 27;105(1B):13S-19S. doi: 10.1016/s0002-9343(98)00070-9.
9
Nonsteroidal anti-inflammatory drug-induced liver injury: a case-control study in primary care.非甾体抗炎药引起的肝损伤:一项初级保健中的病例对照研究。
Fundam Clin Pharmacol. 2004 Apr;18(2):201-6. doi: 10.1111/j.1472-8206.2004.00224.x.
10
Oxaprozin-induced fulminant hepatitis.恶丙嗪诱发的暴发性肝炎。
Ann Pharmacother. 1994 Oct;28(10):1159-61. doi: 10.1177/106002809402801004.

引用本文的文献

1
Salicytamide: a New Anti-inflammatory Designed Drug Candidate.柳氮磺胺吡啶:一种新型抗炎设计药物候选物。
Inflammation. 2018 Aug;41(4):1349-1360. doi: 10.1007/s10753-018-0783-x.
2
The Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review Article.非甾体抗炎药(NSAIDs)在肝病患者治疗中的作用:一篇综述文章。
Anesth Pain Med. 2016 Aug 10;6(4):e37822. doi: 10.5812/aapm.37822. eCollection 2016 Aug.
3
Drug-Induced Liver Injury: Pattern Recognition and Future Directions.药物性肝损伤:模式识别与未来方向

本文引用的文献

1
Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease.非甾体抗炎药在急性肝病方面的安全性。
Arch Intern Med. 1993 Jun 14;153(11):1331-6.
2
Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration.舒林酸相关肝损伤:对向美国食品药品监督管理局报告的91例病例的分析。
Gastroenterology. 1993 Feb;104(2):569-74. doi: 10.1016/0016-5085(93)90428-f.
3
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors.
Gut Liver. 2016 Jan;10(1):27-36. doi: 10.5009/gnl15114.
4
Evaluation of the brain, renal, and hepatic effects of flunixin meglumine, ketoprofen, and phenylbutazone administration in Iranian fat-tailed sheep.
Trop Anim Health Prod. 2011 Oct;43(7):1389-93. doi: 10.1007/s11250-011-9866-5. Epub 2011 Apr 19.
5
Cost-effectiveness analysis of NSAIDs, NSAIDs with concomitant therapy to prevent gastrointestinal toxicity, and COX-2 specific inhibitors in the treatment of rheumatoid arthritis.非甾体抗炎药、联用预防胃肠道毒性疗法的非甾体抗炎药以及COX-2特异性抑制剂治疗类风湿关节炎的成本效益分析
Rheumatol Int. 2005 Jan;25(1):9-14. doi: 10.1007/s00296-003-0392-2. Epub 2003 Sep 12.
Arch Intern Med. 1994 Feb 14;154(3):311-6. doi: 10.1001/archinte.1994.00420030117012.
4
The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs.在接触多种药物的人群中,急性肝损伤住院风险增加。
Epidemiology. 1993 Nov;4(6):496-501.
5
Sulindac (Clinoril) hepatitis.
Gastroenterology. 1981 Mar;80(3):585-6.
6
Jaundice associated with naproxen.与萘普生相关的黄疸
Postgrad Med J. 1980 May;56(655):368-70. doi: 10.1136/pgmj.56.655.368.
7
Life-threatening hypersensitivity to sulindac.对舒林酸的危及生命的超敏反应。
JAMA. 1980 Jul 18;244(3):269-70.
8
Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature.保泰松所致肝损伤:23例临床病理调查及文献复习
Hepatology. 1981 May-Jun;1(3):255-63. doi: 10.1002/hep.1840010311.
9
Hepatitis associated with use of sulindac in a child.一名儿童使用舒林酸后出现的肝炎。
J Pediatr. 1981 Oct;99(4):650-1. doi: 10.1016/s0022-3476(81)80283-1.
10
Sulindac hepatotoxicity.舒林酸肝毒性。
Gut. 1982 Oct;23(10):875-7. doi: 10.1136/gut.23.10.875.